Controlling and Protecting Copiers and Printers Necessary to Secure Healthcare Data
– By Gabriela Garner, Product Marketing Director at Kofax The use of electronic health records…
Month: July 2021
CI&T Acquires Dextra to Scale Local and Global Operations
LONDON, July 1, 2021 – CI&T, a digital specialist for global brands, today announced the…
BOSCO Connect: The First Tool To Accurately Predict Campaign ROI For Online Retailers
Online Retail Guesswork Becomes A Thing Of The Past MarTech innovator Modo25 (www.modo25.com) has announced…
Completion of share buy-back program
Company Announcement COPENHAGEN, Denmark; July 01, 2021 – Genmab A/S (Nasdaq: GMAB) announces that its share…
Transparency Notification
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. PUBLICATION RELATING TO A TRANSPARENCY NOTIFICATION (ARTICLE 14, 1ST PARAGRAPH,…
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel…
Nicox’s NCX 470 Demonstrates Significant Intraocular Pressure Lowering in Dolomites Phase 2 Glaucoma Trial
Press Release Nicox’s NCX 470 Demonstrates Significant Intraocular Pressure Lowering in Dolomites Phase 2 Glaucoma…
Sequana Medical Announces Positive Results From Second Interim Analysis of North American Pivotal alfapump® Study (POSEIDON)
Interim data from 26 patients in the Roll-In Cohort reconfirm positive outcomes against all primary…
Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema
Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new…
Addex, Stanford University and University of Copenhagen Publish mGlu2 Structure in Nature Using Addex Allosteric Modulators
Ad Hoc Announcement Pursuant to Art. 53 LR Data could enable acceleration of lead optimization…
Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…
Bone Therapeutics secures up to €16 million loan financing from the European Investment Bank to accelerate ongoing clinical and commercial development of innovative orthopedic treatment
REGULATED INFORMATION The EIB financing to be used for Bone Therapeutics’ allogeneic cell therapy platform…
Valneva Continues Ongoing Discussions with the European Commission for Inactivated COVID-19 Vaccine Candidate
Saint-Herblain (France), July 1, 2021 – Following a media article published yesterday, Valneva SE, (Nasdaq:…
EXMceuticals Inc. Announces Resignation of Board Members
VANCOUVER, British Columbia, June 30, 2021 (GLOBE NEWSWIRE) — EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company”…
Acumen Pharmaceuticals Announces Pricing of Upsized Initial Public Offering
CHARLOTTESVILLE, Va., June 30, 2021 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (“Acumen” or “Acumen Pharmaceuticals”)…
Aligos Therapeutics Announces Pricing of $83.6 Million Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., June 30, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS)…
Kymera Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
WATERTOWN, Mass., June 30, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage…
Ensysce Biosciences to Commence Trading on the OTC on July 1, 2021
SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
Mesoblast Provides Update on Program for Chronic Low Back Pain Due to Degenerative Disc Disease
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Avicanna Financial Statement Update
TORONTO, June 30, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN)…